Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Medical Oncology and Gynecology

Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute

Amsterdam

Name/email consistency: medium

Department of Medical Oncology and Gynecology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam. 1999
Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, and Department of Pharmacy and Pharmacology, Slotervaart Hospital/Netherlands Cancer Institute, Netherlands. 1999
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, Netherlands. 1996 - 1998

Phase I and pharmacologic study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer. Herben, V.M., Panday, V.R., Richel, D.J., Schellens, J.H., van der Vange, N., Rosing, H., Beusenberg, F.D., Hearn, S., Doyle, E., Beijnen, J.H., ten Bokkel Huinink, W.W. J. Clin. Oncol. (1999) [Pubmed]
Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors. Herben, V.M., Schellens, J.H., Swart, M., Gruia, G., Vernillet, L., Beijnen, J.H., ten Bokkel Huinink, W.W. J. Clin. Oncol. (1999) [Pubmed]
Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors. Herben, V.M., Ten Bokkel Huinink, W.W., Schellens, J.H., Beijnen, J.H. Pharm. World. Sci (1998) [Pubmed]
Clinical pharmacokinetics of topotecan. Herben, V.M., ten Bokkel Huinink, W.W., Beijnen, J.H. Clin. Pharmacokinet (1996) [Pubmed]